These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11547460)

  • 1. Osteopenia in HIV infection.
    Carr A
    AIDS Clin Care; 2001 Aug; 13(8):71-3, 78. PubMed ID: 11547460
    [No Abstract]   [Full Text] [Related]  

  • 2. Accelerated bone mineral loss in HIV-positive patients.
    Laurence J
    AIDS Read; 2000 Apr; 10(4):192, 200. PubMed ID: 10808594
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone disorders in human immunodeficiency virus infection.
    Glesby MJ
    Clin Infect Dis; 2003; 37 Suppl 2():S91-5. PubMed ID: 12942380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV therapeutics: past, present, and future.
    Abu-ata O; Slim J; Perez G; Smith SM
    Adv Pharmacol; 2000; 49():1-40. PubMed ID: 11013759
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of anitiretroviral therapy on bone tissue metabolism in patients with HIV].
    Olczak A; Pawłowska M; Drózdz W
    Przegl Epidemiol; 2008; 62(1):155-62. PubMed ID: 18536239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The latest word on lipodystrophy and mitochondrial toxicity (and old words that still resound).
    Mascolini M
    IAPAC Mon; 2002 Jan; 8(1):14-32. PubMed ID: 11858198
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus.
    Guo JJ; Jang R; Louder A; Cluxton RJ
    Pharmacotherapy; 2005 Aug; 25(8):1044-54. PubMed ID: 16207094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals.
    Mannheimer SB; Wold N; Gardner EM; Telzak EE; Huppler Hullsiek K; Chesney M; Wu AW; MacArthur RD; Matts J; Friedland G;
    Clin Infect Dis; 2008 Mar; 46(6):941-5. PubMed ID: 18279044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the aetiology of dyslipidaemia and hyperlipidaemia in patients with HIV.
    Moyle G
    Int J STD AIDS; 2005 Oct; 16 Suppl 1():14-20; discussion 20-2, 41-3. PubMed ID: 16238827
    [No Abstract]   [Full Text] [Related]  

  • 10. [Are bones in HIV-infected patient really fragile?].
    Biver E; Ciaffi L; Rizzoli R; Calmy A
    Rev Med Suisse; 2013 Jun; 9(390):1246-50. PubMed ID: 23821841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and pathogenesis of diabetes mellitus in treated HIV-infection.
    Paik IJ; Kotler DP
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):469-78. PubMed ID: 21663840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid metabolism in treated HIV Infection.
    Dubé MP; Cadden JJ
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):429-42. PubMed ID: 21663837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
    Carr A; Miller J; Eisman JA; Cooper DA
    AIDS; 2001 Apr; 15(6):703-9. PubMed ID: 11371684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy affects the composition of weight loss in HIV infection: implications for clinical nutrition.
    Maia BS; Engelson ES; Wang J; Kotler DP
    Clin Nutr; 2005 Dec; 24(6):971-8. PubMed ID: 16095765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enduringly effective and tolerable initial therapy of HIV. Even after 5 years no resistance].
    MMW Fortschr Med; 2003 Dec; 145(50):60-1. PubMed ID: 14963980
    [No Abstract]   [Full Text] [Related]  

  • 16. Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients.
    Duvivier C; Kolta S; Assoumou L; Ghosn J; Rozenberg S; Murphy RL; Katlama C; Costagliola D;
    AIDS; 2009 Apr; 23(7):817-24. PubMed ID: 19363330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current HIV therapeutics: mechanistic and chemical determinants of toxicity.
    Chiao SK; Romero DL; Johnson DE
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):53-60. PubMed ID: 19152213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing issues related to antiretroviral therapy.
    Lesho EP; Gey DC
    Am Fam Physician; 2003 Aug; 68(4):675-86. PubMed ID: 12952384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A note about Viagra.
    Treat Rev; 1998; (No 28):15. PubMed ID: 11365423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects.
    Bongiovanni M; Fausto A; Cicconi P; Aliprandi A; Cornalba G; Bini T; Sardanelli F; D'Arminio Monforte A
    J Antimicrob Chemother; 2006 Aug; 58(2):485-6. PubMed ID: 16751202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.